AONC AMERICAN ONCOLOGY NETWORK INC

American Oncology Network Announces First Quarter 2024 Earnings Release Date and Conference Call

American Oncology Network Announces First Quarter 2024 Earnings Release Date and Conference Call

FORT MYERS, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), one of the fastest growing community-based oncology practices, announced today that the Company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day.

To access the call through a conference line, dial 1-877-704-4453 or for international callers, 1-201-389-0920. The passcode for the live call is 13746298. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The Access ID for the replay call is 13746298. The replay will be available until Wednesday, May 22, 2024.

The financial results and live webcast will be accessible through the Investor Relations section of the Company's website at investors.aoncology.com.

About American Oncology Network

American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 240 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.

Investor Contact:

David Gould, Chief Financial Officer



EN
30/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AMERICAN ONCOLOGY NETWORK INC

 PRESS RELEASE

American Oncology Network Announces Second Quarter 2024 Earnings Relea...

American Oncology Network Announces Second Quarter 2024 Earnings Release Date and Conference Call FORT MYERS, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (OTCQX: AONC), one of the fastest growing community-based oncology practices, announced today that the Company will release its second quarter 2024 financial results on Wednesday, August 14, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day. To access the call through a conference line...

 PRESS RELEASE

American Oncology Network Announces the Commencement of OTCQX Trading

American Oncology Network Announces the Commencement of OTCQX Trading FORT MYERS, Fla., June 10, 2024 (GLOBE NEWSWIRE) --  (AON) (OTCQX: AONC), a rapidly-growing network of community-based oncology practices, today announced it has qualified to trade on the OTCQX® Best Market. AON previously traded on NASDAQ. The OTCQX Best Market provides value and convenience to U.S. investors, brokers and institutions seeking to trade AONC. The OTCQX Best Market is premier market for established, investor-focused U.S. and international companies. It offers investors transparent trading in companies ...

 PRESS RELEASE

American Oncology Network Announces Voluntary Delisting From Nasdaq

American Oncology Network Announces Voluntary Delisting From Nasdaq FORT MYERS, Fla., May 21, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), a rapidly growing network of community-based oncology practices, announced today its decision to voluntarily delist its Class A common stock and warrants from The Nasdaq Capital Market ("Nasdaq"). The Company’s decision to delist its securities from Nasdaq was recommended to the Board of Directors (the "Board") of the Company by a Special Committee (the "Special Committee") of the Board comprised solely of...

 PRESS RELEASE

American Oncology Network, Inc. Announces First Quarter 2024 Financial...

American Oncology Network, Inc. Announces First Quarter 2024 Financial Results First Quarter 2024 Highlights Revenue of $364.3 million increased by 20.0% compared to the prior year quarter Patient encounter growth of 7.1% as compared to the prior year quarter Added 17 new providers to the AON platform Expanded in Texas and Maryland markets FORT MYERS, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- American Oncology Network, Inc. (NASDAQ: AONC), a leading oncology platform with an innovative model of physician-led, community-based oncology management, today announced financial results f...

 PRESS RELEASE

American Oncology Network Announces Date Change for First Quarter 2024...

American Oncology Network Announces Date Change for First Quarter 2024 Earnings Release Date and Conference Call FORT MYERS, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), one of the fastest growing community-based oncology practices, announced today that the Company will change the release date of its first quarter 2024 financial results to Monday, May 20, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time the following day. To access the...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch